Taiga Nishihori Selected Research

Taiga Nishihori Research Topics

Disease

38	Graft vs Host Disease (Graft-Versus-Host Disease) 11/2022 - 02/2011
29	Neoplasms (Cancer) 10/2022 - 11/2002
27	Multiple Myeloma 12/2022 - 10/2011
19	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 10/2022 - 06/2014
14	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2022 - 10/2010
13	Lymphoma (Lymphomas) 12/2021 - 09/2013
12	Leukemia 10/2022 - 06/2015
9	B-Cell Lymphoma (Lymphoma, B Cell) 01/2022 - 01/2020
9	Infections 11/2021 - 09/2013
8	Bronchiolitis Obliterans Syndrome 11/2022 - 10/2010
7	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 11/2022 - 03/2016
6	Plasma Cell Leukemia 07/2022 - 12/2011
6	Hematologic Neoplasms (Hematological Malignancy) 07/2021 - 01/2017
5	Cytokine Release Syndrome 01/2022 - 01/2020
4	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 12/2020 - 01/2016
3	Mantle-Cell Lymphoma (Lymphoma, Mantle Cell) 11/2021 - 10/2015
3	Hodgkin Disease (Hodgkin's Disease) 01/2021 - 10/2015
3	Pathologic Complete Response 01/2020 - 03/2016
3	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 01/2020 - 11/2014
3	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 01/2019 - 01/2018
3	Non-Hodgkin Lymphoma (Lymphosarcoma) 01/2018 - 06/2015
2	Chronic Myelomonocytic Leukemia (Leukemia, Chronic Myelomonocytic) 04/2022 - 05/2017
2	Amyloidosis 01/2022 - 11/2015
2	T-Cell Prolymphocytic Leukemia (Leukemia, T Cell, Chronic) 01/2022 - 01/2018
2	Immunoglobulin Light-chain Amyloidosis 01/2022 - 01/2022
2	Cytomegalovirus Infections (Inclusion Disease) 10/2021 - 01/2015
2	Cytopenia 01/2021 - 09/2013
2	Chromosome Aberrations (Chromosome Abnormalities) 01/2021 - 01/2020
2	Primary Myelofibrosis (Myelosclerosis) 12/2020 - 11/2010
2	Thrombotic Microangiopathies 01/2020 - 09/2011
2	Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular) 01/2018 - 10/2015
2	Peripheral T-Cell Lymphoma (Lymphoma, T Cell, Peripheral) 05/2016 - 10/2015
1	POEMS Syndrome (Syndrome, POEMS) 12/2022
1	COVID-19 10/2022
1	Hemorrhage 01/2022
1	Cryptogenic Organizing Pneumonia 01/2022
1	Obesity 01/2022
1	Pneumonia (Pneumonitis) 01/2022
1	cell-associated neurotoxicity 01/2021

Drug/Important Bio-Agent (IBA)

14	Cyclophosphamide (Cytoxan)FDA LinkGeneric 11/2022 - 10/2015
11	Tacrolimus (Prograf)FDA LinkGeneric 01/2022 - 12/2012
9	Melphalan (Alkeran)FDA LinkGeneric 11/2021 - 06/2012
8	Busulfan (Busulfex)FDA Link 11/2021 - 10/2010
8	Methotrexate (Mexate)FDA LinkGeneric 01/2019 - 12/2012
7	fludarabineIBA 11/2021 - 02/2011
7	axicabtagene ciloleucelIBA 01/2021 - 01/2020
7	Calcineurin InhibitorsIBA 01/2021 - 09/2011
6	GlucocorticoidsIBA 11/2022 - 10/2010
6	Bortezomib (Velcade)FDA Link 01/2022 - 06/2012
6	Rituximab (Mabthera)FDA Link 01/2020 - 02/2011
5	Dexamethasone (Maxidex)FDA LinkGeneric 01/2022 - 01/2014
5	Sirolimus (Rapamycin)FDA Link 01/2022 - 09/2011
5	Chimeric Antigen ReceptorsIBA 12/2021 - 01/2021
5	Lenalidomide (CC 5013)FDA Link 02/2017 - 09/2013
4	AntigensIBA 01/2021 - 09/2013
3	Mycophenolic Acid (Cellcept)FDA LinkGeneric 01/2021 - 01/2019
3	SteroidsIBA 01/2021 - 11/2014
3	Antilymphocyte Serum (Anti-Thymocyte Globulin)IBA 01/2020 - 01/2016
3	Alemtuzumab (Campath)FDA Link 01/2020 - 09/2013
3	Cyclosporine (Ciclosporin)FDA LinkGeneric 01/2019 - 10/2015
2	ofatumumab FDA Link 11/2022 - 06/2015
2	InterferonsIBA 01/2021 - 10/2005
2	Anti-Bacterial Agents (Antibiotics)IBA 01/2021 - 01/2021
2	Tyrosine Kinase InhibitorsIBA 01/2020 - 01/2020
2	Etoposide (VP 16)FDA LinkGeneric 01/2019 - 10/2015
2	Biological ProductsIBA 10/2017 - 01/2017
2	liposomal doxorubicin (Doxil)FDA Link 11/2015 - 01/2014
2	Glucose (Dextrose)FDA LinkGeneric 09/2015 - 02/2011
1	Prednisone (Sone)FDA LinkGeneric 11/2022
1	Oxygen (Dioxygen)IBA 10/2022
1	ixazomibIBA 07/2022
1	Tumor Biomarkers (Tumor Markers)IBA 01/2022
1	Immunoglobulins (Immunoglobulin)IBA 01/2022
1	Immunoglobulin Light Chains (Immunoglobulin Light Chain)IBA 01/2022
1	IgKIBA 01/2022
1	T-Cell Antigen Receptors (T-Cell Receptor)IBA 01/2022
1	Immunoconjugates (Immunoconjugate)IBA 07/2021
1	CalcineurinIBA 01/2021
1	LigandsIBA 01/2021
1	Cephalosporins (Cephalosporin Antibiotics)IBA 01/2021
1	Ferritins (Ferritin)IBA 01/2021
1	tocilizumab (atlizumab)FDA Link 01/2021
1	tisagenlecleucelIBA 01/2021
1	Monoclonal AntibodiesIBA 01/2021

Therapy/Procedure

96	Cell Transplantation 12/2022 - 10/2010
44	Therapeutics 11/2022 - 10/2005
29	Transplantation 10/2022 - 02/2011
17	Homologous Transplantation 07/2022 - 10/2010
15	Hematopoietic Stem Cell Transplantation 10/2022 - 11/2011
11	Drug Therapy (Chemotherapy) 01/2022 - 09/2015
11	Autologous Transplantation 01/2022 - 09/2013
4	Stem Cell Transplantation 01/2021 - 01/2019
3	Immunotherapy 07/2021 - 09/2013
2	Photopheresis 10/2017 - 11/2014
1	Artificial Respiration (Mechanical Ventilation) 10/2022
1	Donor Selection 03/2022
1	MDC protocol 01/2022
1	Salvage Therapy 01/2022
1	Aftercare (After-Treatment) 01/2021
1	Length of Stay 01/2021